Ftse Mib
35.952,34
-0,53%
DAX
20.975,10
-0,14%
S&P 500
5.996,66
1,00%
NASDAQ
19.630,20
0,00%
Bitcoin
104.227,66
2,16%
Pepperstone
Advertisement
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Inhibrx Biosciences Inc (INBX) Inhibrx Biosciences Inc (INBX) Notizie

Inhibrx Biosciences Inc

INBX
12,90
-0,59 (-4,37%)
Pre Mercato
Ultimo aggiornamento: 13:02:17
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
13/1/202522:15PRNUSInhibrx Biosciences Announces Loan Agreement with Oxford..
14/11/202422:24PRNUSInhibrx Biosciences Reports Third Quarter 2024 Financial..
04/11/202422:00PRNUSInhibrx Prevails in Trade Secret Case, Reaffirming Its..
14/8/202400:54PRNUSInhibrx Biosciences Reports Second Quarter 2024 Financial..
31/5/202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/5/202400:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/5/202422:34EDGAR2Form S-8 POS - Securities to be offered to employees in..
30/5/202422:32EDGAR2Form POSASR - Post-effective Amendment to an automatic shelf..
30/5/202422:13EDGAR2Form 8-K - Current report
28/5/202422:55EDGAR2Form 144 - Report of proposed sale of securities
25/5/202400:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/5/202422:44EDGAR2Form 3 - Initial statement of beneficial ownership of..
24/5/202422:08EDGAR2Form 8-K - Current report
24/5/202422:00PRNUSInhibrx Inc. Stockholders Approve Sale of INBRX-101 to..
22/5/202415:54EDGAR2Form 144 - Report of proposed sale of securities
21/5/202403:48EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
17/5/202423:29EDGAR2Form 8-K - Current report
17/5/202422:25EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
11/5/202400:36PRNUSInhibrx, Inc. Announces Updated When-Issued Trading Date for..
09/5/202422:08EDGAR2Form 8-K - Current report
08/5/202422:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/5/202422:42EDGAR2Form 8-K - Current report
08/5/202422:37PRNUSInhibrx, Inc. Announces Record Date and Expected..
06/5/202423:16EDGAR2Form 144 - Report of proposed sale of securities
11/3/202421:26EDGAR2Form 144 - Report of proposed sale of securities
08/3/202422:08EDGAR2Form 144 - Report of proposed sale of securities
08/3/202421:28EDGAR2Form 144 - Report of proposed sale of securities
06/3/202422:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202420:58EDGAR2Form 144 - Report of proposed sale of securities
05/3/202400:26EDGAR2Form 144 - Report of proposed sale of securities
29/2/202423:26EDGAR2Form PREM14A - Preliminary proxy statements relating to..
28/2/202415:15PRNUSInhibrx Reports Fourth Quarter and Fiscal Year 2023..
28/2/202415:12EDGAR2Form 8-K - Current report
28/2/202415:10EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
14/2/202422:12EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
06/2/202422:30EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
26/1/202418:12PRNUSKuehn Law Encourages DOC, BATL, KAMN, and INBX Investors to..
23/1/202423:25EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
23/1/202412:38EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
23/1/202412:35EDGAR2Form 8-K - Current report
23/1/202412:05DJNSanofi to Buy Assets From Inhibrx in Deal Valued at Up to..
23/1/202411:40IHMARKETNEWSWall Street Highlights: Vroom Shuts Down Online Car Sales,..
23/1/202407:00PRNUSInhibrx Announces Sale of INBRX-101 to Sanofi for an..
Apertura: Min: Max:
Chiusura: 13,49

La tua Cronologia

NASDAQ
INBX
Inhibrx Biosciences
BIT
P1T8L0
BNP Paribas Issuance
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network